DK162190A - Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer - Google Patents

Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer Download PDF

Info

Publication number: DK162190A
Authority: DK; Denmark
Prior art keywords: treatment; adenocarcinoma; transcriptase inhibitors; revers; revers transcriptase
Prior art date: 1988-01-07

Application number

DK162190A

Other languages

English (en)

Other versions

DK173766B1 (da

DK162190D0 (da

Inventor

Charles Anthony Hart

Kevin Mccarthy

Samuel John Leinster

Christopher Douglas Green

Ayad Mohamed Khala Al-Sumidaie

Original Assignee

Univ Liverpool

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-01-07

Filing date

1990-07-05

Publication date

1990-07-05

1990-07-05 Application filed by Univ Liverpool filed Critical Univ Liverpool

1990-07-05 Publication of DK162190D0 publication Critical patent/DK162190D0/da

1990-07-05 Publication of DK162190A publication Critical patent/DK162190A/da

2001-09-24 Application granted granted Critical

2001-09-24 Publication of DK173766B1 publication Critical patent/DK173766B1/da

Links

238000011282 treatment Methods 0.000 title abstract 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 title 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 title 1
208000009956 adenocarcinoma Diseases 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
206010006187 Breast cancer Diseases 0.000 abstract 1
208000026310 Breast neoplasm Diseases 0.000 abstract 1
201000009030 Carcinoma Diseases 0.000 abstract 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
239000003419 rna directed dna polymerase inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Materials For Medical Uses (AREA)

DK199001621A 1988-01-07 1990-07-05 Anvendelse af 3'-azido-3'-deoxythimidin til fremstilling af et medikament til behandling af brystscarcinoma hos mennesker DK173766B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB888800276A GB8800276D0 (en)	1988-01-07	1988-01-07	Medical treatment
GB8800276		1988-01-07
PCT/GB1989/000010 WO1989006132A1 (en)	1988-01-07	1989-01-06	Reverse transcriptase inhibitors for treating adenocarcinomas
GB8900010		1989-01-06

Publications (3)

Publication Number	Publication Date
DK162190D0 DK162190D0 (da)	1990-07-05
DK162190A true DK162190A (da)	1990-07-05
DK173766B1 DK173766B1 (da)	2001-09-24

Family

ID=10629601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK199001621A DK173766B1 (da)	1988-01-07	1990-07-05	Anvendelse af 3'-azido-3'-deoxythimidin til fremstilling af et medikament til behandling af brystscarcinoma hos mennesker

Country Status (15)

Country	Link
US (1)	US5223490A (da)
EP (1)	EP0327200B1 (da)
JP (1)	JP2761420B2 (da)
KR (1)	KR900700110A (da)
CN (1)	CN1034134A (da)
AT (1)	ATE83378T1 (da)
AU (1)	AU626284B2 (da)
CA (1)	CA1331138C (da)
DE (1)	DE68903840T2 (da)
DK (1)	DK173766B1 (da)
GB (1)	GB8800276D0 (da)
IE (1)	IE63788B1 (da)
MY (1)	MY104462A (da)
WO (1)	WO1989006132A1 (da)
ZA (1)	ZA8993B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823353D0 (en) *	1988-10-05	1988-11-09	Wellcome Found	Therapeutic nucleosides
FR2649982B1 (fr) *	1989-07-20	1991-09-27	Inst Nat Sante Rech Med	Membrane biologique artificielle
US5405837A (en) *	1993-05-18	1995-04-11	Indiana University Foundation	Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
US5576177A (en) *	1994-03-09	1996-11-19	St. Jude Children's Research Hospital	Bioassay for reverse transcriptase inhibitors
EP1174141A3 (en) *	1996-01-23	2003-04-23	ICN Pharmaceuticals, Inc.	Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes
PE20000066A1 (es) *	1997-12-22	2000-02-09	Schering Corp	Formas de dosificacion solida de ribavirina administrables oralmente y proceso de fabricacion
US7351542B2 (en) *	2002-05-20	2008-04-01	The Regents Of The University Of California	Methods of modulating tubulin deacetylase activity
WO2005090316A1 (en) *	2004-03-12	2005-09-29	Wyeth	HYDANTOINS HAVING RNase MODULATORY ACTIVITY
US20050203176A1 (en) *	2004-03-12	2005-09-15	Wyeth	Carbamates as HIV anti-viral agents
WO2005090320A2 (en) *	2004-03-12	2005-09-29	Wyeth	Triazole derivatives and method of using the same to treat hiv infections
US7553967B2 (en) *	2004-03-12	2009-06-30	Wyeth	1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
US8497292B2 (en)	2005-12-28	2013-07-30	Translational Therapeutics, Inc.	Translational dysfunction based therapeutics
WO2007123579A2 (en) *	2005-12-28	2007-11-01	Translational Therapeutics	Translational dysfunction based therapeutics
US7725227B2 (en) *	2006-12-15	2010-05-25	Gm Global Technology Operations, Inc.	Method, system, and apparatus for providing enhanced steering pull compensation
TW202228724A (zh) *	2020-09-23	2022-08-01	美商昂克萊亞製藥公司	以反轉錄酶抑制劑治療癌症之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE73219B1 (en) *	1985-03-16	1997-05-07	Wellcome Found	Therapeutic nucleosides
GB8506869D0 (en) *	1985-03-16	1985-04-17	Wellcome Found	Antiviral compound
AU570853B2 (en) *	1985-08-26	1988-03-24	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
DD262802A5 (de) *	1985-09-17	1988-12-14	The Wellcome Foundation Limited,Gb	Verfahren zur herstellung einer pharmazeutischen formulierung

1988
- 1988-01-07 GB GB888800276A patent/GB8800276D0/en active Pending
1989
- 1989-01-04 MY MYPI89000008A patent/MY104462A/en unknown
- 1989-01-04 CA CA000587506A patent/CA1331138C/en not_active Expired - Fee Related
- 1989-01-05 ZA ZA8993A patent/ZA8993B/xx unknown
- 1989-01-06 EP EP89300099A patent/EP0327200B1/en not_active Expired - Lifetime
- 1989-01-06 IE IE3689A patent/IE63788B1/en not_active IP Right Cessation
- 1989-01-06 JP JP1501527A patent/JP2761420B2/ja not_active Expired - Lifetime
- 1989-01-06 WO PCT/GB1989/000010 patent/WO1989006132A1/en not_active Ceased
- 1989-01-06 AT AT89300099T patent/ATE83378T1/de active
- 1989-01-06 KR KR1019890701666A patent/KR900700110A/ko not_active Withdrawn
- 1989-01-06 DE DE8989300099T patent/DE68903840T2/de not_active Expired - Lifetime
- 1989-01-06 US US07/536,669 patent/US5223490A/en not_active Expired - Lifetime
- 1989-01-06 AU AU29498/89A patent/AU626284B2/en not_active Ceased
- 1989-01-07 CN CN89100192A patent/CN1034134A/zh active Pending
1990
- 1990-07-05 DK DK199001621A patent/DK173766B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH03503049A (ja)	1991-07-11
EP0327200A1 (en)	1989-08-09
DK173766B1 (da)	2001-09-24
DK162190D0 (da)	1990-07-05
ATE83378T1 (de)	1993-01-15
CN1034134A (zh)	1989-07-26
AU2949889A (en)	1989-08-01
JP2761420B2 (ja)	1998-06-04
GB8800276D0 (en)	1988-02-10
WO1989006132A1 (en)	1989-07-13
CA1331138C (en)	1994-08-02
DE68903840T2 (de)	1993-06-17
IE890036L (en)	1989-07-07
KR900700110A (ko)	1990-08-11
AU626284B2 (en)	1992-07-30
IE63788B1 (en)	1995-06-14
DE68903840D1 (de)	1993-01-28
EP0327200B1 (en)	1992-12-16
US5223490A (en)	1993-06-29
MY104462A (en)	1994-04-30
ZA8993B (en)	1989-10-25

Legal Events

Date	Code	Title
1997-06-16	PBP	Patent lapsed
2001-09-24	B1	Patent granted (law 1993)
2009-01-26	PUP	Patent expired

Publication	Publication Date	Title
DK162190A (da)	1990-07-05	Revers-transcriptase-inhibitorer til behandling af adenocarcinomaer
DK130387A (da)	1987-09-15	Transglutaminase inhibitorer
FI872720A7 (fi)	1987-12-21	Neutraaliset metalliendopeptidaasi-inhibiittorit hypertension hoidossa
DK177690D0 (da)	1990-07-26	Behandling af fedme
NO894337L (no)	1990-05-08	Hydrolyserte kopolymerer av n-vinylamid og akrylamid for bruk som vanntapsregulerende additiver i boreslam.
NO904622D0 (no)	1990-10-25	Aprotininanaloger og fremgangsmaate for fremstilling derav.
FI915152A7 (fi)	1992-05-02	HIV-käänteistranskriptaasi-inhibiittoreiden synergismi
IT8920364A0 (it)	1989-05-03	Trattamento della superficie di un tessuto duro.
NO894840D0 (no)	1989-12-04	Tilsetningsmiddel for broennbehandlingsfluider.
DK168189D0 (da)	1989-04-07	Topisk praeparat til behandling af otopati
DK0530937T3 (da)	1999-05-10	Inhibitor med collagenfremkaldt blodpladeaggregering
NO157403C (no)	1988-03-23	Middel for behandling av saar.
DE69007695D1 (de)	1994-05-05	Fucosidase-Inhibitoren.
DE68908344D1 (de)	1993-09-16	Oberflaechenbehandlung von metallen.
EP0270782A3 (en)	1990-01-03	Therapeutic agents for the prophylaxis of tumour metastasis
EP0147707A3 (en)	1985-08-07	1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IT8967717A0 (it)	1989-08-24	Trattamento di superfici
DK159088A (da)	1988-09-25	Overfladebehandlingskompostition
IT1208370B (it)	1989-06-12	Dispositivo circuitale per determinare la presenza o la rimozione di oggetti particolarmente strumenti per trattamenti odontoiatrici
FI912926A7 (fi)	1991-12-19	HIV-käänteistranskriptaasin inhibiittoreita
ATE155686T1 (de)	1997-08-15	Hemmung von metastasen bei krebspatienten mit pyridyloxazol-2-onen
DK332786A (da)	1986-07-11	Anvendelse af 1,4-dihydropyridinderivater og kombinationer deraf med calcitoniner
FR2508909B1 (da)	1983-12-23
DK70283D0 (da)	1983-02-17	Kombination af tavle og tilhoerende skinner samt fremgangsmade til brug af samme
SE8701177L (sv)	1988-09-24	Arbetsmoebel med staellbart stativ